Don't let it get away!
Keep track of the stocks that matter to you.
Help yourself with the Fool's FREE and easy new watchlist service today.
GSI characterized the acquisition as just one step in a "medical component market strategy, which has been in process for over a year," but also as complementary to GSI's existing lines of medical products. In a press release, the company noted that it has a "number of shared customers [with NDS], which we expect will strengthen the Company's key OEM customer relationships."
Going forward, the company says it expects "nearly 40%" of its revenues to come from the medical market. The NDS transaction in particular is expected to produce $80 million in annual revenue and to be accretive to GSI's earnings in 2013.
Shares of GSI rose 10.3% on the news to $9.34.